Combination Antiretroviral Use and Preterm Birth

D. Heather Watts(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Kenneth Rich(University of Illinois Chicago), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Deborah Kacanek(Cancer Research And Biostatistics), Ray Griner(Cancer Research And Biostatistics), Herman Mendez(SUNY Downstate Health Sciences University), Paige L. Williams(Cancer Research And Biostatistics), Rohan Hazra
The Journal of Infectious Diseases
November 29, 2012
10.1093/infdis/jis728
Cited by 125

Related Papers

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
|BMJ|2020|2.4k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697
Measles Antibody: Reevaluation of Protective Titers
|The Journal of Infectious Diseases|1990|612